Etoposide, doxorubicin, cyclophosphamide and high-dose betamethasone (EACB) as outpatient salvage therapy for refractory multiple myeloma.
Autor: | Ohrling, M., Björkholm, M., Österborg, A., Juliusson, G., Björeman, M., Brenning, G., Carlson, K., Celsing, F., Gahrton, G., Grimfors, G., Gruber, A., Gyllenhammar, H., Hast, R., Johansson, B., Järnmark, M., Kimby, E., Lerner, R., Linder, O., Merk, K., Paul, C. |
---|---|
Zdroj: | European Journal of Haematology; Jul1993, Vol. 51 Issue 1, p45-49, 5p |
Databáze: | Complementary Index |
Externí odkaz: |